Viewing on a PDA? Click here to read this email.
Medical Progress Today
mpt home | sign up

Volume 7, Number 25
June 24, 2010


In the Spotlight

Congress's Medicare Canary

Diana Furchtgott-Roth, Real Clear Markets, 6-24-10

Pity the nation's seniors. Just as the first baby-boomers (born in 1946) are preparing to sign up for Medicare in 2011, Congress has cut the fees that Medicare will pay to physicians, ensuring that docs take fewer Medicare patients. Or has it?
Continue reading . . .


· Medical Device Recalls and the FDA Approval Process, Zuckerman, D. M., Brown, P., Nissen, S. E., Archives of Internal Medicine, 6-14-11
· Patent Reform Gets Key Support in House, Julian Pecquet, The Hill, 6-14-11
· $4.3 Billion Pledged at Vaccine Fund-Raiser, Donald G. McNeil Jr., New York Times, 6-13-2011
· Physicians Leaving Practices for health System Employment, Karen Cheung, FierceHealthcare, 6-13-11

More Headlines >>


· Marco Rubio takes on 'Medi-scare' Marc A. Thiessen, Washington Post, 6-13-11
· 'Vouchercare' Is the Right Name for Medicare Laurence Kotlikoff, Bloomberg, 6-15-11
· Built To Fail: Health Insurance Exchanges Under The Affordable Care Act
· Can Exchanges Help Consumers Get Good Value Insurance? Depends On Where You Live Sabrina Corlette, Kaiser Health News, 6-15-11
· The ObamaCare Bad News Continues Karl Rove, Wall Street Journal, 6-16-11
· ObamaCare's Economic Flaws Doug Holtz-Eakin, Investor's Business Daily, 6-8-11

More Commentary >>


· Why States Are So Miffed about Medicaid Economics, Politics, and the "Woodwork Effect", Benjamin D. Sommers et al., New England Journal of Medicine, 6-15-11
· Auditing Access to Specialty Care for Children with Public Insurance, Joanna bisgaier et al., New England Journal of Medicine, 6-16-11
· Moving Beyond Fee-For-Service: The Case for Managed Care in Medicaid, Michael Ramlet and Carey Lafferty, American Action Forum, 6-14-11
· The New Gold Rush: Prospectors are Hoping to Mine Opportunities in the Healthcare Industry, Health Research Institute, PricewatershouseCoopers, 6-14-11
· Active Purchasing for Health Insurance Exchanges: An Analysis of Options, Sabrina Corlette and JoAnn Volk, RWJF, 6-14-11

More Research>>

Medical Progress Today is published by the Center for Medical Progress at the Manhattan Institute for Policy Research.

For more information about Medical Progress Today, please contact the managing editor, Paul Howard, at, or via telephone at 212.599.7000.

Press inquiries regarding Medical Progress Today can be directed to the Communications Department, at, or via telephone at 212.599.7000.

If you would like to unsubscribe, please reply to us and type "Unsubscribe" in the subject line.


Congress's Medicare Canary

Cost of Caution: The Impact on Patients of Delayed Drug Approvals
By Tomas J. Philipson and Eric Sun

The FDA's lengthy pre-application process for new drugs slows access to new treatments. For the first time ever, authors Tomas Philipson and Eric Sun calculate the costs of patients' lives lost to drug-development delays.

Podcast Series

This week, Tomas J. Philipson and Eric Sun discuss their new report, "Cost of Caution: The Impact on Patients of Delayed Drug Approvals," and how to save lives by streamlining the FDA's drug-development process. The report was released last week on Capitol Hill to influential staffers, scholars, and policy makers.

Click here to listen to the podcast.

"What this report is concerned with is essentially that even though the latter part of the [FDA's drug-approval process], the time that FDA takes to evaluate the [trial] data, has gone down dramatically, . . . the time to conduct these trials from phase one to three has not, and that's really the bulk of development time from idea to market . . . . And that is really what affects patients waiting for these treatments to go on the market."
—Tomas Philipson


Center for Medical Progress 
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000